Global Hereditary Transthyretin Amyloidosis (HATTR) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Hereditary Transthyretin Amyloidosis (HATTR) market size was valued at US$ million in 2023. With growing demand in downstream market, the Hereditary Transthyretin Amyloidosis (HATTR) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hereditary Transthyretin Amyloidosis (HATTR) market. Hereditary Transthyretin Amyloidosis (HATTR) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hereditary Transthyretin Amyloidosis (HATTR). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hereditary Transthyretin Amyloidosis (HATTR) market.
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR). Mutations in the gene for TTR frequently result in instability of TTR and subsequent fibril formation. HATTR can be sub-classified into familial amyloid polyneuropathy (FAP) and familial amyloid cardiomyopathy (FAC). The deposition of TTR amyloid fibrils in various tissues leads to ATTR, including Familial ATTR (hereditary ATTR) and non-hereditary ATTR types. Familial ATTR is a rare disorder with unequal distribution all around the world.
Key Features:
The report on Hereditary Transthyretin Amyloidosis (HATTR) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hereditary Transthyretin Amyloidosis (HATTR) market. It may include historical data, market segmentation by Type (e.g., Oral, Subcutaneous Injection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hereditary Transthyretin Amyloidosis (HATTR) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hereditary Transthyretin Amyloidosis (HATTR) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hereditary Transthyretin Amyloidosis (HATTR) industry. This include advancements in Hereditary Transthyretin Amyloidosis (HATTR) technology, Hereditary Transthyretin Amyloidosis (HATTR) new entrants, Hereditary Transthyretin Amyloidosis (HATTR) new investment, and other innovations that are shaping the future of Hereditary Transthyretin Amyloidosis (HATTR).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hereditary Transthyretin Amyloidosis (HATTR) market. It includes factors influencing customer ' purchasing decisions, preferences for Hereditary Transthyretin Amyloidosis (HATTR) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hereditary Transthyretin Amyloidosis (HATTR) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hereditary Transthyretin Amyloidosis (HATTR) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hereditary Transthyretin Amyloidosis (HATTR) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hereditary Transthyretin Amyloidosis (HATTR) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hereditary Transthyretin Amyloidosis (HATTR) market.
Market Segmentation:
Hereditary Transthyretin Amyloidosis (HATTR) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Hereditary Transthyretin Amyloidosis (HATTR) market size was valued at US$ million in 2023. With growing demand in downstream market, the Hereditary Transthyretin Amyloidosis (HATTR) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hereditary Transthyretin Amyloidosis (HATTR) market. Hereditary Transthyretin Amyloidosis (HATTR) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hereditary Transthyretin Amyloidosis (HATTR). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hereditary Transthyretin Amyloidosis (HATTR) market.
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR). Mutations in the gene for TTR frequently result in instability of TTR and subsequent fibril formation. HATTR can be sub-classified into familial amyloid polyneuropathy (FAP) and familial amyloid cardiomyopathy (FAC). The deposition of TTR amyloid fibrils in various tissues leads to ATTR, including Familial ATTR (hereditary ATTR) and non-hereditary ATTR types. Familial ATTR is a rare disorder with unequal distribution all around the world.
Key Features:
The report on Hereditary Transthyretin Amyloidosis (HATTR) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hereditary Transthyretin Amyloidosis (HATTR) market. It may include historical data, market segmentation by Type (e.g., Oral, Subcutaneous Injection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hereditary Transthyretin Amyloidosis (HATTR) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hereditary Transthyretin Amyloidosis (HATTR) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hereditary Transthyretin Amyloidosis (HATTR) industry. This include advancements in Hereditary Transthyretin Amyloidosis (HATTR) technology, Hereditary Transthyretin Amyloidosis (HATTR) new entrants, Hereditary Transthyretin Amyloidosis (HATTR) new investment, and other innovations that are shaping the future of Hereditary Transthyretin Amyloidosis (HATTR).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hereditary Transthyretin Amyloidosis (HATTR) market. It includes factors influencing customer ' purchasing decisions, preferences for Hereditary Transthyretin Amyloidosis (HATTR) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hereditary Transthyretin Amyloidosis (HATTR) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hereditary Transthyretin Amyloidosis (HATTR) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hereditary Transthyretin Amyloidosis (HATTR) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hereditary Transthyretin Amyloidosis (HATTR) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hereditary Transthyretin Amyloidosis (HATTR) market.
Market Segmentation:
Hereditary Transthyretin Amyloidosis (HATTR) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Oral
- Subcutaneous Injection
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Alnylam Pharmaceuticals
- Akcea Therapeutics
- Prothena
- Lonis Pharmaceuticals
- Eidos Therapeutics
- Corino Therapeutics Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2030
2.1.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hereditary Transthyretin Amyloidosis (HATTR) Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous Injection
2.2.3 Others
2.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
2.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
2.4 Hereditary Transthyretin Amyloidosis (HATTR) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
2.5.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
3 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET SIZE BY PLAYER
3.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Players
3.1.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2019-2024)
3.1.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Players (2019-2024)
3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) BY REGIONS
4.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions (2019-2024)
4.2 Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth (2019-2024)
4.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth (2019-2024)
4.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth (2019-2024)
4.5 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2019-2024)
5.2 Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024)
5.3 Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2019-2024)
6.2 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024)
6.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) by Country (2019-2024)
7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024)
7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) by Region (2019-2024)
8.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024)
8.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET FORECAST
10.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Regions (2025-2030)
10.1.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Regions (2025-2030)
10.1.2 Americas Hereditary Transthyretin Amyloidosis (HATTR) Forecast
10.1.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Forecast
10.1.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Forecast
10.1.5 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Forecast
10.2 Americas Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Country (2025-2030)
10.2.1 United States Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.2.2 Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.2.3 Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.2.4 Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Region (2025-2030)
10.3.1 China Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.2 Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.3 Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.4 Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.5 India Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.6 Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Country (2025-2030)
10.4.1 Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4.2 France Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4.3 UK Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4.4 Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4.5 Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Region (2025-2030)
10.5.1 Egypt Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5.2 South Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5.3 Israel Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5.4 Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5.5 GCC Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.6 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Type (2025-2030)
10.7 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Information
11.2.2 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alnylam Pharmaceuticals Main Business Overview
11.2.5 Alnylam Pharmaceuticals Latest Developments
11.3 Akcea Therapeutics
11.3.1 Akcea Therapeutics Company Information
11.3.2 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Akcea Therapeutics Main Business Overview
11.3.5 Akcea Therapeutics Latest Developments
11.4 Prothena
11.4.1 Prothena Company Information
11.4.2 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Prothena Main Business Overview
11.4.5 Prothena Latest Developments
11.5 Lonis Pharmaceuticals
11.5.1 Lonis Pharmaceuticals Company Information
11.5.2 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lonis Pharmaceuticals Main Business Overview
11.5.5 Lonis Pharmaceuticals Latest Developments
11.6 Eidos Therapeutics
11.6.1 Eidos Therapeutics Company Information
11.6.2 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eidos Therapeutics Main Business Overview
11.6.5 Eidos Therapeutics Latest Developments
11.7 Corino Therapeutics Inc
11.7.1 Corino Therapeutics Inc Company Information
11.7.2 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Corino Therapeutics Inc Main Business Overview
11.7.5 Corino Therapeutics Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2030
2.1.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hereditary Transthyretin Amyloidosis (HATTR) Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous Injection
2.2.3 Others
2.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
2.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
2.4 Hereditary Transthyretin Amyloidosis (HATTR) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
2.5.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
3 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET SIZE BY PLAYER
3.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Players
3.1.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2019-2024)
3.1.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Players (2019-2024)
3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) BY REGIONS
4.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions (2019-2024)
4.2 Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth (2019-2024)
4.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth (2019-2024)
4.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth (2019-2024)
4.5 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2019-2024)
5.2 Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024)
5.3 Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2019-2024)
6.2 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024)
6.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) by Country (2019-2024)
7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024)
7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) by Region (2019-2024)
8.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024)
8.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) MARKET FORECAST
10.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Regions (2025-2030)
10.1.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Regions (2025-2030)
10.1.2 Americas Hereditary Transthyretin Amyloidosis (HATTR) Forecast
10.1.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Forecast
10.1.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Forecast
10.1.5 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Forecast
10.2 Americas Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Country (2025-2030)
10.2.1 United States Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.2.2 Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.2.3 Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.2.4 Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3 APAC Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Region (2025-2030)
10.3.1 China Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.2 Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.3 Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.4 Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.5 India Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.3.6 Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Country (2025-2030)
10.4.1 Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4.2 France Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4.3 UK Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4.4 Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.4.5 Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Region (2025-2030)
10.5.1 Egypt Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5.2 South Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5.3 Israel Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5.4 Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.5.5 GCC Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast
10.6 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Type (2025-2030)
10.7 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Information
11.2.2 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alnylam Pharmaceuticals Main Business Overview
11.2.5 Alnylam Pharmaceuticals Latest Developments
11.3 Akcea Therapeutics
11.3.1 Akcea Therapeutics Company Information
11.3.2 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Akcea Therapeutics Main Business Overview
11.3.5 Akcea Therapeutics Latest Developments
11.4 Prothena
11.4.1 Prothena Company Information
11.4.2 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Prothena Main Business Overview
11.4.5 Prothena Latest Developments
11.5 Lonis Pharmaceuticals
11.5.1 Lonis Pharmaceuticals Company Information
11.5.2 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lonis Pharmaceuticals Main Business Overview
11.5.5 Lonis Pharmaceuticals Latest Developments
11.6 Eidos Therapeutics
11.6.1 Eidos Therapeutics Company Information
11.6.2 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eidos Therapeutics Main Business Overview
11.6.5 Eidos Therapeutics Latest Developments
11.7 Corino Therapeutics Inc
11.7.1 Corino Therapeutics Inc Company Information
11.7.2 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
11.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Corino Therapeutics Inc Main Business Overview
11.7.5 Corino Therapeutics Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Subcutaneous Injection
Table 4. Major Players of Others
Table 5. Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 8. Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 11. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Player (2019-2024)
Table 13. Hereditary Transthyretin Amyloidosis (HATTR) Key Players Head office and Products Offered
Table 14. Hereditary Transthyretin Amyloidosis (HATTR) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Regions (2019-2024)
Table 19. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Country (2019-2024)
Table 23. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 25. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 27. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Region (2019-2024)
Table 29. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 31. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 33. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Country (2019-2024)
Table 35. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 37. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Hereditary Transthyretin Amyloidosis (HATTR)
Table 46. Key Market Challenges & Risks of Hereditary Transthyretin Amyloidosis (HATTR)
Table 47. Key Industry Trends of Hereditary Transthyretin Amyloidosis (HATTR)
Table 48. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Pfizer Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 53. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 54. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Alnylam Pharmaceuticals Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 58. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 59. Alnylam Pharmaceuticals Main Business
Table 60. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Alnylam Pharmaceuticals Latest Developments
Table 62. Akcea Therapeutics Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 63. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 64. Akcea Therapeutics Main Business
Table 65. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Akcea Therapeutics Latest Developments
Table 67. Prothena Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 68. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 69. Prothena Main Business
Table 70. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Prothena Latest Developments
Table 72. Lonis Pharmaceuticals Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 73. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 74. Lonis Pharmaceuticals Main Business
Table 75. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Lonis Pharmaceuticals Latest Developments
Table 77. Eidos Therapeutics Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 78. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 79. Eidos Therapeutics Main Business
Table 80. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Eidos Therapeutics Latest Developments
Table 82. Corino Therapeutics Inc Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 83. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 84. Corino Therapeutics Inc Main Business
Table 85. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Corino Therapeutics Inc Latest Developments
Table 1. Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Subcutaneous Injection
Table 4. Major Players of Others
Table 5. Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 8. Hereditary Transthyretin Amyloidosis (HATTR) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 11. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Player (2019-2024)
Table 13. Hereditary Transthyretin Amyloidosis (HATTR) Key Players Head office and Products Offered
Table 14. Hereditary Transthyretin Amyloidosis (HATTR) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Regions (2019-2024)
Table 19. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Country (2019-2024)
Table 23. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 25. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 27. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Region (2019-2024)
Table 29. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 31. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 33. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Country (2019-2024)
Table 35. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 37. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Hereditary Transthyretin Amyloidosis (HATTR)
Table 46. Key Market Challenges & Risks of Hereditary Transthyretin Amyloidosis (HATTR)
Table 47. Key Industry Trends of Hereditary Transthyretin Amyloidosis (HATTR)
Table 48. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Pfizer Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 53. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 54. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Alnylam Pharmaceuticals Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 58. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 59. Alnylam Pharmaceuticals Main Business
Table 60. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Alnylam Pharmaceuticals Latest Developments
Table 62. Akcea Therapeutics Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 63. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 64. Akcea Therapeutics Main Business
Table 65. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Akcea Therapeutics Latest Developments
Table 67. Prothena Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 68. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 69. Prothena Main Business
Table 70. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Prothena Latest Developments
Table 72. Lonis Pharmaceuticals Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 73. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 74. Lonis Pharmaceuticals Main Business
Table 75. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Lonis Pharmaceuticals Latest Developments
Table 77. Eidos Therapeutics Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 78. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 79. Eidos Therapeutics Main Business
Table 80. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Eidos Therapeutics Latest Developments
Table 82. Corino Therapeutics Inc Details, Company Type, Hereditary Transthyretin Amyloidosis (HATTR) Area Served and Its Competitors
Table 83. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Offered
Table 84. Corino Therapeutics Inc Main Business
Table 85. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Corino Therapeutics Inc Latest Developments
LIST OF FIGURES
Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Hereditary Transthyretin Amyloidosis (HATTR) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Hereditary Transthyretin Amyloidosis (HATTR) Sales Market Share by Country/Region (2023)
Figure 8. Hereditary Transthyretin Amyloidosis (HATTR) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type in 2023
Figure 10. Hereditary Transthyretin Amyloidosis (HATTR) in Hospital
Figure 11. Global Hereditary Transthyretin Amyloidosis (HATTR) Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Hereditary Transthyretin Amyloidosis (HATTR) in Clinic
Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Hereditary Transthyretin Amyloidosis (HATTR) in Others
Figure 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application in 2023
Figure 17. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Player in 2023
Figure 18. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Country in 2023
Figure 24. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Region in 2023
Figure 29. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type in 2023
Figure 30. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application in 2023
Figure 31. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Country in 2023
Figure 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 57. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 61. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 65. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 68. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 69. UK Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 78. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Hereditary Transthyretin Amyloidosis (HATTR) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Hereditary Transthyretin Amyloidosis (HATTR) Sales Market Share by Country/Region (2023)
Figure 8. Hereditary Transthyretin Amyloidosis (HATTR) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type in 2023
Figure 10. Hereditary Transthyretin Amyloidosis (HATTR) in Hospital
Figure 11. Global Hereditary Transthyretin Amyloidosis (HATTR) Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Hereditary Transthyretin Amyloidosis (HATTR) in Clinic
Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Hereditary Transthyretin Amyloidosis (HATTR) in Others
Figure 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application in 2023
Figure 17. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Player in 2023
Figure 18. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Country in 2023
Figure 24. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Region in 2023
Figure 29. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type in 2023
Figure 30. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application in 2023
Figure 31. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Country in 2023
Figure 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 57. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 61. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 65. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 68. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 69. UK Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Size 2025-2030 ($ Millions)
Figure 78. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share Forecast by Application (2025-2030)
